Then we tested the dynamics of protein aggregation induced by drugs, and the data indicated that Lapatinib (LAP), a small-molecule tyrosine kinase inhibitor of EGFR and HER2, caused protein aggregation at 30 min and that CIS caused protein aggregation at 1 h. The gene discussed is EGFR; the disease is in situ carcinoma.